Skip to main content

Articles

Page 2 of 73

  1. The main focus on the characteristics of malignant lung tumours has been the size, position within the lobe, and infiltration into neighbouring structures. The aim of this study was to investigate the distribu...

    Authors: Yngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, Åslaug Helland, Bjørn Møller, Sissel Gyrid Freim Wahl and Steinar Solberg
    Citation: BMC Pulmonary Medicine 2024 24:106
  2. While the prevalence of severe cases and mortality rate of coronavirus disease 2019 (COVID-19) appear to be reducing, the clinical characteristics and severity of hospitalized patients with asthma and COVID-19...

    Authors: Akinari Tsukada, Junko Terada-Hirashima, Jin Takasaki, Hiroshi Nokihara, Shinyu Izumi, Masayuki Hojo and Haruhito Sugiyama
    Citation: BMC Pulmonary Medicine 2024 24:105
  3. Ventilator-associated pneumonia (VAP) is one of the leading causes of mortality in patients with critical care illness. Since obesity is highly prevalent, we wanted to study its impact on the outcomes of patie...

    Authors: Mohamad El Labban, Michella Abi Zeid Daou, Hiba Smaily, Abbas Hammoud, Ghandi Hassan, Syed Khan and Imad Bou Akl
    Citation: BMC Pulmonary Medicine 2024 24:104
  4. Randomized controlled trials described beneficial effects of inhaled triple therapy (LABA/LAMA/ICS) in patients with chronic obstructive pulmonary disease (COPD) and high risk of exacerbations. We studied whet...

    Authors: Jennifer A. Zader, Rudolf A. Jörres, Imke Mayer, Peter Alter, Robert Bals, Henrik Watz, Pontus Mertsch, Klaus F. Rabe, Felix Herth, Franziska C. Trudzinski, Tobias Welte, Hans-Ulrich Kauczor, Jürgen Behr, Julia Walter, Claus F. Vogelmeier and Kathrin Kahnert
    Citation: BMC Pulmonary Medicine 2024 24:103
  5. To investigate pulmonary thromboembolism (PE) in acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) patients in plateau regions, we performed a prospective cohort study to evaluate the preva...

    Authors: Chenlu Yang, Yajun Tuo, Xuefeng Shi, Jie Duo, Xin Liu, Fang Zhang and Xiaokai Feng
    Citation: BMC Pulmonary Medicine 2024 24:102
  6. Pulmonary arterial hypertension is a serious medical condition. However, the condition is often misdiagnosed or a rather long delay occurs from symptom onset to diagnosis, associated with decreased 5-year surv...

    Authors: Shun Imai, Seiichiro Sakao, Jun Nagata, Akira Naito, Ayumi Sekine, Toshihiko Sugiura, Ayako Shigeta, Akira Nishiyama, Hajime Yokota, Norihiro Shimizu, Takeshi Sugawara, Toshiaki Nomi, Seiwa Honda, Keisuke Ogaki, Nobuhiro Tanabe, Takayuki Baba…
    Citation: BMC Pulmonary Medicine 2024 24:101
  7. Tuberculosis (TB) is a significant global health concern, given its high rates of morbidity and mortality. The diagnosis using urine lipoarabinomannan (LAM) primarily benefits HIV co-infected TB patients with ...

    Authors: Yan Li, Zhiwei Ru, Hongxia Wei, Ming Wu, Guihua Xie, Jianrong Lou, Xiang Yang and Xilin Zhang
    Citation: BMC Pulmonary Medicine 2024 24:100
  8. The most common and potentially fatal side effect of thoracic radiation therapy is radiation pneumonitis (RP). Due to the lack of effective treatments, predicting radiation pneumonitis is crucial. This study a...

    Authors: Yawen Zha, Jingjing Zhang, Xinyu Yan, Chen Yang, Lei Wen and Minying Li
    Citation: BMC Pulmonary Medicine 2024 24:99
  9. The concept of eosinophilic bronchiectasis has received clinical attention recently, but the association between blood eosinophil count (BEC) and hospital characteristics has rarely been reported yet. We aim t...

    Authors: Chengcheng Lei, Zhimin Zeng, Fengjia Chen, Yubiao Guo and Yangli Liu
    Citation: BMC Pulmonary Medicine 2024 24:98
  10. While cutaneous melanomas are well-documented, primary melanoma of the lung (PMML), particularly with endobronchial origin, remains rare and poorly characterized. This case report addresses gaps in understandi...

    Authors: Emanuela Barisione, Andrea Boutros, Marco Mora, Francesco Spagnolo, Enrica Teresa Tanda, Carlo Genova and Elena Tagliabue
    Citation: BMC Pulmonary Medicine 2024 24:97
  11. Advanced lung adenocarcinoma patients often develop resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs), leaving uncertainties regarding subsequent treatment strategies. Although personalized therapy tar...

    Authors: Kan Jiang, Lin Wu, Xinlong Zheng, Yiquan Xu, Qian Miao, Xiaobin Zheng, Longfeng Zhang, Cheng Huang and Gen Lin
    Citation: BMC Pulmonary Medicine 2024 24:96
  12. Asthma is a common respiratory disease. In asthma, the small airways have more intensive inflammation and prominent airway remodelling, compared to the central airways. We aimed to investigate the predictive v...

    Authors: Lulu Zhang, Zhou Fu, Hua Deng, Qin Xie and Wenjie Wu
    Citation: BMC Pulmonary Medicine 2024 24:94
  13. To evaluate the efficacy of high-flow nasal cannula oxygenation (HFNC) versus non-invasive ventilation (NIV) in pediatric patients post-congenital heart surgery (CHS) through a meta-analysis.

    Authors: Si-Jia Zhou, Xiu-Hua Chen, Ying-Ying Liu, Qiang Chen, Yi-Rong Zheng and Qi-Liang Zhang
    Citation: BMC Pulmonary Medicine 2024 24:92
  14. Alpha1-antitrypsin (AAT) is a serine protease inhibitor that serves as a counterbalance to the activity of elastases, e.g., neutrophil elastase in lung tissue. AAT deficiency (AATD) is a rare disorder usually ...

    Authors: Dilek KaradoÄŸan, Ãœnal Åžahin, Bettina Dreger, Laura Grandoso and Lourdes Osaba
    Citation: BMC Pulmonary Medicine 2024 24:91
  15. The data on bosentan were lacking for the treatment of exercise-induced elevation of pulmonary artery pressure (eePAP) or less severe PH in COPD. This study was conducted to investigate long-term efficacy and ...

    Authors: Takeru Kashiwada, Yosuke Tanaka, Toru Tanaka, Tetsuya Okano, Yoshinobu Saito, Masahiro Seike, Mitsunori Hino, Hiroshi Kimura and Akihiko Gemma
    Citation: BMC Pulmonary Medicine 2024 24:90
  16. Several studies have indicated that intrapleural infusion of bevacizumab is an effective treatment for non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE). However, the impact of bevacizum...

    Authors: Hao Zeng, Yuanyuan Zhang, Sihan Tan, Qin Huang, Xin Pu, Panwen Tian and Yalun Li
    Citation: BMC Pulmonary Medicine 2024 24:89
  17. Incentive spirometry (IS) as a routine respiratory therapy during the perioperative period has been widely used in clinical practice. However, the impact of IS on patients with perioperative lung cancer remain...

    Authors: Yan Liang, Shaolin Chen, Jiamei Song, Ting Deng, Jinfen Yang, Yangyang Long, Lorna Kwai Ping Suen and Xu Luo
    Citation: BMC Pulmonary Medicine 2024 24:88
  18. Interstitial lung diseases (ILDs) are caused by inflammation and/or fibrosis of alveolar walls resulting in impaired gas exchange. Hypersensitivity pneumonitis (HP) is the third most common type of ILDs. Corti...

    Authors: Marwa G. Elhennawy, Yosri Akl, Maggie Abbassi and Nirmeen A. Sabry
    Citation: BMC Pulmonary Medicine 2024 24:87
  19. The new endobronchial therapy called biological lung volume reduction (BioLVR) involves using a rapid polymerizing sealant to block off the most emphysematous portions of the lungs. The primary mechanism of ac...

    Authors: Dina Abd El Wahab El Gohary, Mohamed Adel Eltomey, Ahmed Shawky Mohamed, Amgad Abd El Raouf Farahat and Ayman Hassan Abd El Zaher
    Citation: BMC Pulmonary Medicine 2024 24:86
  20. Lung adenocarcinoma (LUAD) has high morbidity and mortality. Despite substantial advances in treatment, the prognosis of patients with LUAD remains unfavorable. The ceRNA axis has been reported to play an impo...

    Authors: Jiang Wu, Guang Fu, Chao Luo, Liang Chen and Quanxing Liu
    Citation: BMC Pulmonary Medicine 2024 24:85
  21. Exposure assessment is integral to the diagnosis of hypersensitivity pneumonitis (HP). Although the clinical relevance of exposed antigens is essential for the assessment, many of the previous guidelines or re...

    Authors: Yuki Iijima, Masaru Ejima, Takashi Yamana, Shiro Sonoda, Sho Shibata, Tsuyoshi Shirai, Tsukasa Okamoto, Haruhiko Furusawa, Tomoya Tateishi, Takuya Adachi, Mio Mori, Susumu Kirimura, Tatsuhiko Anzai, Kunihiko Takahashi and Yasunari Miyazaki
    Citation: BMC Pulmonary Medicine 2024 24:84
  22. Respiratory complications in breast cancer (BC) patients after chemotherapy (CT) and radiotherapy (RT) have been well acquainted and these complications should be investigated to prevent secondary problems and...

    Authors: Alper Tuğral, Zeynep Arıbaş, Murat Akyol and Yeşim Bakar
    Citation: BMC Pulmonary Medicine 2024 24:83
  23. There is a need to develop and validate a widely applicable nomogram for predicting readmission of respiratory failure patients within 365 days.

    Authors: Zhongxiang Liu, Zhixiao Sun, Hang Hu, Yuan Yin and Bingqing Zuo
    Citation: BMC Pulmonary Medicine 2024 24:82
  24. Elevation of systemic inflammatory markers were found to correlate with increased disease extent, reduced lung function and higher risk of future severe exacerbations in patients with bronchiectasis. Although ...

    Authors: Wang Chun Kwok, Kay Cheong Teo, Kui Kai Lau and James Chung-man HO
    Citation: BMC Pulmonary Medicine 2024 24:80
  25. Trauma has been identified as one of the risk factors for acute respiratory distress syndrome. Respiratory support can be further complicated by comorbidities of trauma such as primary or secondary lung injury...

    Authors: Jing Su, Xin Tie, Yao Chen, Tongjuan Zou and Wanhong Yin
    Citation: BMC Pulmonary Medicine 2024 24:79
  26. Pulmonary hypertension (PH) is a complication of chronic kidney disease (CKD) that contributes to mortality. Sclerostin, a SOST gene product that reduces osteoblastic bone formation by inhibiting Wnt/β-catenin...

    Authors: Jonghyun Lee, Dong-Hyuk Cho, Hyeon-Jin Min, Young-Bin Son, Tae Bum Kim, Se Won Oh, Myung-Gyu Kim, Won Yong Cho, Sang-Kyung Jo and Jihyun Yang
    Citation: BMC Pulmonary Medicine 2024 24:78
  27. This study aimed to investigate the risk factors for peripheral arteriosclerosis (PAS) and peripheral artery disease (PAD) in chronic obstructive pulmonary disease (COPD) patients and potential ultrasound indi...

    Authors: Li Lin, Yuting Yan, Bin Jiang, Gang Hou, Yan Yin, Lei Wang, Jian Kang and Qiuyue Wang
    Citation: BMC Pulmonary Medicine 2024 24:77
  28. Severe asthma places a large burden on patients and society. The characteristics of patients with severe asthma in the Chinese population remain unclear.

    Authors: Guiping Zhu, Yuqing Mo, Ling Ye, Hui Cai, Yingying Zeng, Mengchan Zhu, Wenjun Peng, Xin Gao, Xixi Song, Chengyu Yang, Jian Wang, Zhihong Chen and Meiling Jin
    Citation: BMC Pulmonary Medicine 2024 24:76
  29. Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare disease characterized by pulmonary radiological alterations, peripheral eosinophilia, and demonstrated pulmonary eosinophilia. Oral steroids (OSs) are...

    Authors: Andrea Dionelly Murillo, Ana Isabel Castrillon, Carlos Daniel Serrano and Liliana Fernandez-Trujillo
    Citation: BMC Pulmonary Medicine 2024 24:74
  30. While several traditional observational studies have suggested associations between gut microbiota and asthma, these studies are limited by factors such as participant selection bias, confounders, and reverse ...

    Authors: Jingli Li, Chunyi Zhang, Jixian Tang, Meng He, Chunxiao He, Guimei Pu, Lingjing Liu and Jian Sun
    Citation: BMC Pulmonary Medicine 2024 24:72
  31. One of the most prevalent respiratory disorders in modern society is chronic obstructive pulmonary disease (COPD). Frequent comorbidities in patients with COPD are abnormal nutritional status and body composit...

    Authors: M. Yogesh, Jenish Patel, Naresh Makwana and Mansi Mody
    Citation: BMC Pulmonary Medicine 2024 24:71
  32. Viral infection is a risk factor for asthma exacerbation (AE). However, bacterial infections related to AE in adults are poorly known. On the other hand, obese patients with asthma have their own clinical and ...

    Authors: Sojung Park, Yong Il Hwang, Sei Won Lee, Hyo-Jung Kim, Byung-Keun Kim, Jin Hwa Lee, Yon Ju Ryu, So Ri Kim and Jung Hyun Chang
    Citation: BMC Pulmonary Medicine 2024 24:69
  33. Information on the performance of oxygenation indices (OIs) and risk scores in patients requiring invasive mechanical ventilation (IMV) is limited. We determine the performance of the OIs and risk scores in ho...

    Authors: Alirio R. Bastidas-Goyes, Eduardo Tuta-Quintero, Maria F. Aguilar, Angélica V. Mora, Hermencia C. Aponte, Jesus M. Villamizar, Susana Galeano, Paola Mejia, Maria Muñoz, Sara Paredes, Doris Pumarejo and Maria Del Mar Barragan
    Citation: BMC Pulmonary Medicine 2024 24:68
  34. We present a case of an inflammatory myofibroblastic tumor cured with a short period of steroid administration, a treatment previously unreported for such cases.

    Authors: Ryo Watanabe, Satoshi Ano, Norihiro Kikuchi, Michiko Saegusa, Rie Shigemasa, Yuzuru Kondo and Nobuyuki Hizawa
    Citation: BMC Pulmonary Medicine 2024 24:67
  35. Self-management (SM) is the key factor in controlling the progression of chronic obstructive pulmonary disease (COPD). Previous studies have reported that majority of COPD patients later presented with frailty...

    Authors: Jie Zhao, Xiaona Zhang, Xindan Li, Rui Zhang, Yan Chang, Yongju Li and Hongyan Lu
    Citation: BMC Pulmonary Medicine 2024 24:66
  36. Exercise is crucial for pulmonary rehabilitation and improving the prognosis of lung transplantation (LTx) patients. However, many LTx patients in China have low exercise tolerance and compliance, and the reas...

    Authors: Hui Yang, Saisai Liu, Jingru Chen, Yaxin Qiao, Chengcheng Wang, Wenping Zhang, Li Wei and Ruiyun Chen
    Citation: BMC Pulmonary Medicine 2024 24:65
  37. Asthma and chronic obstructive pulmonary disease (COPD) are common diseases mostly treated in primary care. However, the usage patterns of drugs for obstructive airway diseases (R03 drugs) at the national leve...

    Authors: Pekka Juntunen, Petri Salmela, Johanna Pakkasela, Jussi Karjalainen and Lauri Lehtimäki
    Citation: BMC Pulmonary Medicine 2024 24:64
  38. Much remains unknown about complex respiratory symptoms after COVID-19. Here we aimed to describe and analyse patients’ various respiratory symptoms 4 months after discharge from hospitalisation for COVID-19, ...

    Authors: Monika Fagevik Olsén, Louise Lannefors, Ewa-Lena Johansson and Hanna C. Persson
    Citation: BMC Pulmonary Medicine 2024 24:63
  39. Klotho is an anti-aging protein that has multiple functions and may play a key role in the pathogenesis and progression of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). Fra...

    Authors: Haiyan Mao, Zhenye Xie, Shanshan Huang, Xingkai Shen, Shaofeng Jin, Tong Lin and Zhouxin Yang
    Citation: BMC Pulmonary Medicine 2024 24:61
  40. Obstructive sleep apnea (OSA) is a common sleep-breathing disorder. Numerous investigations have found a strong inherent relationship between OSA and hypothyroidism. Studies suggest that lymphocytes may be inv...

    Authors: Xiaoyan Fang, Le Wang, Chong Xu, Tuai Xue, Mingchu Zhang, Lingling Liu, Jie Cao and Jing Zhang
    Citation: BMC Pulmonary Medicine 2024 24:60
  41. Lung cancer remains a major global health concern due to its high incidence and mortality rates. With advancements in medical treatments, an increasing number of early-stage lung cancer cases are being detecte...

    Authors: Xue-e Su, Shan-hu Wu, He-fan He, Cui-liu Lin, Shu Lin and Pei-qing Weng
    Citation: BMC Pulmonary Medicine 2024 24:59
  42. Randomized controlled trials(RCTs) of multiple drugs for Idiopathic pulmonary fibrosis(IPF) have been reported and achieved a certain degree of efficacy, however, the difference in safety and efficacy of them ...

    Authors: Xiaozheng Wu, Wen Li, Zhenliang Luo and Yunzhi Chen
    Citation: BMC Pulmonary Medicine 2024 24:58
  43. Currently, there remains insufficient focus on non-severe community-acquired pneumonia (CAP) patients who are at risk of clinical deterioration, and there is also a dearth of research on the related risk facto...

    Authors: Cheng-bin Xu, Shan-shan Su, Jia Yu, Xiong Lei, Peng-cheng Lin, Qing Wu, Ying Zhou and Yu-ping Li
    Citation: BMC Pulmonary Medicine 2024 24:57

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal